Cargando…

Plazomicin: a new aminoglycoside in the fight against antimicrobial resistance

OBJECTIVE: To review the mechanism of action, mechanisms of resistance, in vitro activity, pharmacokinetics, pharmacodynamics, and clinical data for a novel aminoglycoside. DATA SOURCES: A PubMed search was performed from January 2006 to August 2019 using the following search terms: plazomicin and A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clark, Justin A., Burgess, David S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475792/ https://www.ncbi.nlm.nih.gov/pubmed/32953108 http://dx.doi.org/10.1177/2049936120952604

Ejemplares similares

2801. Antimicrobial Spectrum of Plazomicin and Other Aminoglycosides against Multidrug-Resistant and Carbapenem-Resistant Enterobacterales When Applying New Breakpoints
por: Sader, Helio S, et al.
Publicado: (2023)

Teaching an Old Class New Tricks: A Novel Semi-Synthetic Aminoglycoside, Plazomicin
por: Abdul-Mutakabbir, Jacinda C., et al.
Publicado: (2019)

1348. In vitro Activity of Plazomicin, a Next-Generation Aminoglycoside, Against Carbapenemase-Producing Klebsiella pneumoniae
por: Jacobs, Michael R, et al.
Publicado: (2018)

Plazomicin against Multidrug-Resistant Bacteria: A Scoping Review
por: Alfieri, Aniello, et al.
Publicado: (2022)

Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance
por: Galani, Irene, et al.
Publicado: (2019)

Correction to: Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance
por: Galani, Irene, et al.
Publicado: (2019)

Impact of the Recent Clinical and Laboratory Standards Institute Breakpoint Changes on the Antimicrobial Spectrum of Aminoglycosides and the Activity of Plazomicin Against Multidrug-Resistant and Carbapenem-Resistant Enterobacterales From United States Medical Centers
por: Sader, Helio S, et al.
Publicado: (2023)

Evaluation of the Bactericidal Activity of Plazomicin and Comparators against Multidrug-Resistant Enterobacteriaceae
por: Thwaites, M., et al.
Publicado: (2018)

Activity of Plazomicin against Enterobacteriaceae Isolates Collected in the United States Including Isolates Carrying Aminoglycoside-Modifying Enzymes Detected by Whole Genome Sequencing
por: Castanheira, Mariana, et al.
Publicado: (2017)

1345. Comparative Activity of Plazomicin and Other Aminoglycosides Against Enterobacteriaceae Isolates From Various Infection Sources From Hospitalized Patients in the United States
por: Castanheira, Mariana, et al.
Publicado: (2018)

Structural basis for plazomicin antibiotic action and resistance
por: Golkar, Tolou, et al.
Publicado: (2021)

249 Activity of Plazomicin Against Contemporary Isolates of Enterobacteriaceae from New York City
por: Olafisoye, Olawole, et al.
Publicado: (2014)

Inhibition of Enzymatic Acetylation-Mediated Resistance to Plazomicin by Silver Ions
por: Ngo, David, et al.
Publicado: (2023)

Plazomicin Is Active Against Metallo-β-Lactamase-Producing Enterobacteriaceae
por: Serio, Alisa W, et al.
Publicado: (2019)

Fighting Back against Antimicrobial Resistance with Comprehensive Policy and Education: A Narrative Review
por: Hayes, Justin F.
Publicado: (2022)

Antimicrobial Drugs in Fighting against Antimicrobial Resistance
por: Cheng, Guyue, et al.
Publicado: (2016)

2536. Comparing the activity of broad-spectrum beta-lactams in combination with aminoglycosides and aztreonam/avibactam against 8 VIM-producing CRE
por: Clark, Justin A, et al.
Publicado: (2023)

1454. Plazomicin Activity against Enterobacterales Isolates Producing Extended-Spectrum β-Lactamases (ESBLs), Carbapenemases, and Aminoglycoside-Modifying Enzymes (AMEs) from United States (US) Hospitals
por: Castanheira, Mariana, et al.
Publicado: (2020)

Fight Against Antimicrobial Resistance: We Always Need New Antibacterials but for Right Bacteria
por: Duval, Raphaël E., et al.
Publicado: (2019)

1229. Antimicrobial Activity of Plazomicin against Multidrug-resistant Enterobacterales: Results from 3 Years of Surveillance in Hospitals in the United States (2018–2020)
por: Carvalhaes, Cecilia G, et al.
Publicado: (2021)

A New Hope in the Fight Against Antimicrobial Resistance with Artificial Intelligence
por: Tran, Minh-Hoang, et al.
Publicado: (2022)

Phage Products for Fighting Antimicrobial Resistance
por: Huang, Yuanling, et al.
Publicado: (2022)

Medicines quality assurance to fight antimicrobial resistance
por: Nwokike, Jude, et al.
Publicado: (2018)

Discovery science, an ally in the fight against antimicrobial resistance
Publicado: (2022)

Bacteriocins, Potent Antimicrobial Peptides and the Fight against Multi Drug Resistant Species: Resistance Is Futile?
por: Meade, Elaine, et al.
Publicado: (2020)

1227. Plazomicin Susceptibility Testing using ETEST(®) MIC for Enterobacterales
por: Ying, Yun, et al.
Publicado: (2020)

Silicon versus Superbug: Assessing Machine Learning’s Role in the Fight against Antimicrobial Resistance
por: Coxe, Tallon, et al.
Publicado: (2023)

708. In Vitro Activity of Plazomicin vs. Clinical Isolates of Gram-Negative Bacilli, Including Aminoglycoside Nonsusceptible and Multidrug-Resistant Subsets, Recovered from Patients Across Canada as Part of the CANWARD study, 2011–2018
por: Walkty, Andrew, et al.
Publicado: (2019)

Ouabain potentiates the antimicrobial activity of aminoglycosides against Staphylococcus aureus
por: Kumari, Neelam, et al.
Publicado: (2019)

The role of vaccines in fighting antimicrobial resistance (AMR)
por: Jansen, Kathrin U., et al.
Publicado: (2018)

Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health
por: Majumder, Md Anwarul Azim, et al.
Publicado: (2020)

“The Chennai declaration” - Indian doctors’ fight against antimicrobial resistance
por: Voss, Andreas, et al.
Publicado: (2013)

Role of Artificial Intelligence in Fighting Antimicrobial Resistance in Pediatrics
por: Fanelli, Umberto, et al.
Publicado: (2020)

Efficacy and Safety of Plazomicin in the Treatment of Enterobacterales Infections: A Meta-analysis of Randomized Controlled Trials
por: Yan, Kaicheng, et al.
Publicado: (2022)

The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline
por: Frost, Isabel, et al.
Publicado: (2023)

Targeted therapies in breast cancer: New challenges to fight against resistance
por: Masoud, Viviana, et al.
Publicado: (2017)

Multicenter Clinical Evaluation of ETEST Plazomicin (PLZ) for Susceptibility Testing of Enterobacterales
por: Blanchard, Laurine S., et al.
Publicado: (2022)

Antibiotics and Antimicrobials Resistance: Mechanisms and New Strategies to Fight Resistant Bacteria
por: Muller, Cécile
Publicado: (2022)

2162. Comparison of Plazomicin Disk Diffusion vs. Gradient Diffusion Susceptibility Testing Results Against Drug-Resistant Clinical Enterobacteriaceae Isolates
por: Lepak, Alexander, et al.
Publicado: (2019)

Aminoglycosides: Molecular Insights on the Recognition of RNA and Aminoglycoside Mimics
por: Chittapragada, Maruthi, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_49c9cbbsdk8erl1egv11vu33lh